[Recent advances in the study of arachidonic acid-sensitive and mechano-gated tandem-pore-domain potassium channels--TREK].
Li
Zheng-bin
ZB
Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
Wang
Xiao-liang
XL
D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002545:Brain Ischemia / Q000378:metabolism*; D005260:Female; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology; D010053:Ovary / Q000378:metabolism; D015221:Potassium Channels / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D024683:Potassium Channels, Tandem Pore Domain / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D019782:Riluzole / Q000494:pharmacology
C503438:KCNK10 protein, human; C503432:KCNK4 protein, human; D018696:Neuroprotective Agents; D015221:Potassium Channels; D024683:Potassium Channels, Tandem Pore Domain; C103742:potassium channel protein TREK-1; D016718:Arachidonic Acid; D019782:Riluzole